These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 32685011

  • 1. TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization.
    Li Y, Zhang B, Xiang L, Xia S, Kucuk O, Deng X, Boise LH, Dong JT.
    Theranostics; 2020; 10(17):7656-7670. PubMed ID: 32685011
    [Abstract] [Full Text] [Related]

  • 2. Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition.
    Tamaki H, Harashima N, Hiraki M, Arichi N, Nishimura N, Shiina H, Naora K, Harada M.
    Oncotarget; 2014 Nov 30; 5(22):11399-412. PubMed ID: 25333266
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy.
    Jia J, Zhang HB, Shi Q, Yang C, Ma JB, Jin B, Wang X, He D, Guo P.
    Theranostics; 2019 Nov 30; 9(19):5464-5477. PubMed ID: 31534497
    [Abstract] [Full Text] [Related]

  • 5. Polysaccharides from Lentinus edodes prevent acquired drug resistance to docetaxel in prostate cancer cells by decreasing the TGF-β1 secretion of cancer-associated fibroblasts.
    Zhang W, Tao N, Bai L.
    J Nat Med; 2023 Sep 30; 77(4):817-828. PubMed ID: 37354258
    [Abstract] [Full Text] [Related]

  • 6. Nitazoxanide inhibits acetylated KLF5-induced bone metastasis by modulating KLF5 function in prostate cancer.
    Huang Q, Liu M, Zhang D, Lin BB, Fu X, Zhang Z, Zhang B, Dong JT.
    BMC Med; 2023 Feb 21; 21(1):68. PubMed ID: 36810084
    [Abstract] [Full Text] [Related]

  • 7. Bisdemethoxycurcumin Augments Docetaxel Efficacy for Treatment of Prostate Cancer.
    Song Y, Ruan J, Liu S, Yu H.
    Biol Pharm Bull; 2024 Feb 21; 47(8):1437-1446. PubMed ID: 39143009
    [Abstract] [Full Text] [Related]

  • 8. ABL-N may induce apoptosis of human prostate cancer cells through suppression of KLF5, ICAM-1 and Stat5b, and upregulation of Bax/Bcl-2 ratio: An in vitro and in vivo study.
    Zhang Y, Liu K, Zhang Y, Qi J, Lu B, Shi C, Yin Y, Cai W, Li W.
    Oncol Rep; 2015 Dec 21; 34(6):2953-60. PubMed ID: 26397390
    [Abstract] [Full Text] [Related]

  • 9. Prostate cancer cell-derived exosomes ZNF667-AS1 reduces TGFBR1 mRNA stability to inhibit Treg expansion and DTX resistance by binding to U2AF1.
    Shi Z, Pu W, Li M, Aihemaitijiang M, Li S, Zhang X, Liu B, Sun M, Li J, Li Z.
    Mol Med; 2024 Oct 18; 30(1):179. PubMed ID: 39425009
    [Abstract] [Full Text] [Related]

  • 10. Nimbolide enhances the antitumor effect of docetaxel via abrogation of the NF-κB signaling pathway in prostate cancer preclinical models.
    Zhang J, Jung YY, Mohan CD, Deivasigamani A, Chinnathambi A, Alharbi SA, Rangappa KS, Hui KM, Sethi G, Ahn KS.
    Biochim Biophys Acta Mol Cell Res; 2022 Dec 18; 1869(12):119344. PubMed ID: 36007677
    [Abstract] [Full Text] [Related]

  • 11. Eya2 Is Overexpressed in Human Prostate Cancer and Regulates Docetaxel Sensitivity and Mitochondrial Membrane Potential through AKT/Bcl-2 Signaling.
    Liu Z, Zhao L, Song Y.
    Biomed Res Int; 2019 Dec 18; 2019():3808432. PubMed ID: 31317026
    [Abstract] [Full Text] [Related]

  • 12. Ras inhibits TGF-β-induced KLF5 acetylation and transcriptional complex assembly via regulating SMAD2/3 phosphorylation in epithelial cells.
    Guo P, Xing C, Fu X, He D, Dong JT.
    J Cell Biochem; 2020 Mar 18; 121(3):2197-2208. PubMed ID: 31724223
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer.
    Babasaki T, Sentani K, Sekino Y, Kobayashi G, Thang Pham Q, Katsuya N, Akabane S, Taniyama D, Hayashi T, Shiota M, Oue N, Teishima J, Matsubara A, Yasui W.
    Cancer Med; 2021 Aug 18; 10(16):5574-5588. PubMed ID: 34240817
    [Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147.
    Hao J, Madigan MC, Khatri A, Power CA, Hung TT, Beretov J, Chang L, Xiao W, Cozzi PJ, Graham PH, Kearsley JH, Li Y.
    PLoS One; 2012 Aug 18; 7(8):e40716. PubMed ID: 22870202
    [Abstract] [Full Text] [Related]

  • 15. Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models.
    Festuccia C, Gravina GL, D'Alessandro AM, Muzi P, Millimaggi D, Dolo V, Ricevuto E, Vicentini C, Bologna M.
    Endocr Relat Cancer; 2009 Jun 18; 16(2):401-13. PubMed ID: 19153211
    [Abstract] [Full Text] [Related]

  • 16. Protein Disulfide Isomerase 4 Drives Docetaxel Resistance in Prostate Cancer.
    Qian S, Zhang S, Wu Y, Ding Y, ShenDepartment of Urology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China, shenhaibo@xinhuamed.com.cn., Li X.
    Chemotherapy; 2020 Jun 18; 65(5-6):125-133. PubMed ID: 33238278
    [Abstract] [Full Text] [Related]

  • 17. Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer.
    Zhang B, Li Y, Wu Q, Xie L, Barwick B, Fu C, Li X, Wu D, Xia S, Chen J, Qian WP, Yang L, Osunkoya AO, Boise L, Vertino PM, Zhao Y, Li M, Chen HR, Kowalski J, Kucuk O, Zhou W, Dong JT.
    Nat Commun; 2021 Mar 17; 12(1):1714. PubMed ID: 33731701
    [Abstract] [Full Text] [Related]

  • 18. Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism.
    Chen L, Song Y, Hou T, Li X, Cheng L, Li Y, Xing Y.
    J Exp Clin Cancer Res; 2022 Jun 03; 41(1):194. PubMed ID: 35659274
    [Abstract] [Full Text] [Related]

  • 19. Different expression patterns and functions of acetylated and unacetylated Klf5 in the proliferation and differentiation of prostatic epithelial cells.
    Xing C, Fu X, Sun X, Guo P, Li M, Dong JT.
    PLoS One; 2013 Jun 03; 8(6):e65538. PubMed ID: 23755247
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145.
    Kucukzeybek Y, Gul MK, Cengiz E, Erten C, Karaca B, Gorumlu G, Atmaca H, Uzunoglu S, Karabulut B, Sanli UA, Uslu R.
    J Exp Clin Cancer Res; 2008 Sep 12; 27(1):37. PubMed ID: 18789152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.